MarketPulse

product safety

2 articles
BenzingaBenzinga··The Schall Law Firm

RGNX Securities Fraud Lawsuit Opens for Lead Plaintiffs Over RGX-111 Misstatements

Schall Law Firm seeks lead plaintiffs in class action against REGENXBIO for allegedly concealing negative efficacy and safety data on RGX-111 candidate drug.
RGNXsecurities fraudclass action lawsuit
BenzingaBenzinga··Vandana Singh

Insulet Plunges to 52-Week Low After Omnipod 5 Safety Recall

Insulet stock hits 52-week low after voluntary Omnipod 5 recall due to insulin delivery tubing defect. 18 serious adverse events reported.
XHEPODDBCSMTMATtechnical analysis52-week low